Collectively, while chidamide inhibits HDAC3 and its downstream targets, the enhancement of HNF4A acetylation plays a more critical role in regulating TYMS expression and mediating chidamide’s sensitizing effect to 5-FU in GC cells. Here, HDAC3 is linked to gastric cancer.